Cocaine Use Reduction with Buprenorphine (CURB)

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

The aim of this study is to investigate the safety and effectiveness of buprenorphine in the presence of naltrexone for the treatment of cocaine dependence in a sample of individuals meeting diagnostic criteria for both cocaine and opioid dependence or opioid abuse.

CTN Protocol ID: 
CTN-0048
ClinicalTrials.gov ID: 

Principal Investigator(s)

Walter Ling, M.D.
Director
Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Boulevard
Suite 200
Los Angeles, CA 90025
lwalter@ucla.edu

Participating Sites